NCT02982161 - Efficacy and Safety in a Randomised Acute Pain Study of MR308 (Tramadol/Celecoxib). | Biotech Hunter

Enrollment

818

Participants

Timeline

Start Date

December 28, 2016

Primary Completion Date

January 4, 2018

Study Completion Date

January 4, 2018

Conditions

Acute Pain

Interventions

DRUG

MR308

Over-encapsulated tablet, Dosing frequency: two times daily, Mode of administration: oral

DRUG

Tramadol

Over-encapsulated capsule, Dosing frequency: four times daily, Mode of administration: oral

DRUG

Placebo

Capsule, Dosing frequency: four times daily, Mode of administration: oral

Trial Locations (7)

Medical Arts Health Research Group, Penticton

Mount Sinai Hospital, Toronto

University Hospital Greifswald, Greifswald

Semmelweis Egyetem Fogorvostudomnyi Kar, Budapest

Policlinico G.B. Rossi, Verona

POLIMEDICA Centrum Badań, Profilaktyki i Leczenia Sp. z o.o. Sp. k., Zgierz

Facultad de Odontología, Universitat de Barcelona, Barcelona

All Listed Sponsors

lead

Mundipharma Research GmbH & Co KG

INDUSTRY